Trade Summary

4 days ago, Barchas Isaac, serving as Dir at Immunome Inc. (IMNM), sold 100,000 shares at $24.13 per share, for a total transaction value of $2,412,521.54. Following this transaction, Barchas Isaac now holds 108,504 shares of IMNM.

This sale represents a 47.96% decrease in Barchas Isaac's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, July 6, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 7, 2026 at 7:02 PM ET, 1 day after the trade was made.

Immunome Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.